Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hong-Long Zhou"'
Publikováno v:
Neurochemical Research. 41:2708-2718
Human amniotic membrane mesenchymal stem cells (hAMSCs) are considered ideal candidate stem cells for cell-based therapy. In this study, we assessed whether hAMSCs transplantation promotes neurological functional recovery in rats after traumatic spin
Publikováno v:
Biochemical and Biophysical Research Communications. 475:202-208
Human amniotic membrane mesenchymal stem cells (hAMSCs) have recently been suggested as ideal candidate stem cells for cell-based therapy. Many studies have reported the therapeutic effects of hAMSCs in numerous disease models. However, no studies ha
Amniotic Mesenchymal Stem Cells Decrease Aβ Deposition and Improve Memory in APP/PS1 Transgenic Mice
Autor:
Qing-Shan Deng, Ruxiang Xu, Mou Gao, Ke-En Chen, Qiang Fu, Jun Lv, Shanshan Wang, Zhong-jie Yan, Xiang-Yu Wang, Xing-Yu Dong, Mao-Ying Zhang, Yu You, Chuan-Yi Zheng, Qian-Quan Wan, Hong-Long Zhou, Xiao-Yu Zheng, Hui Yao
Publikováno v:
Neurochemical research. 42(8)
Transplantation of human amniotic mesenchymal stem cells (hAM-MSCs) seems to be a promising strategy for the treatment of neurodegenerative disorders, including Alzheimer's disease (AD). However, the clinical therapeutic effects of hAM-MSCs and their
Autor:
Hong-Long Zhou, Hong-tian Zhang, Ruxiang Xu, Yu-Qin Hu, Mao-Ying Zhang, Peng Zhang, Zhong-jie Yan, Sun-Quan Hong
Publikováno v:
Neurochemical research. 38(5)
Although human amnion derived mesenchymal stem cells (AMSC) are a promising source of stem cells, their therapeutic potential for traumatic brain injury (TBI) has not been widely investigated. In this study, we evaluated the therapeutic potential of
Autor:
Zhi-min Xu, Sun-Quan Hong, Mao-Ying Zhang, Hai-lin Zhao, Ruxiang Xu, Tian-Zhu Liu, Yang Guo, Ying-qian Cai, Hong-Long Zhou, Jian You, Xiao-dan Jiang
Publikováno v:
Neuroscience letters. 525(2)
Tenascin-R (TN-R) is a neural specific protein and an important molecule involved in inhibition of axonal regeneration after spinal cord injury (SCI). Here we report on rabbit-derived TN-R polyclonal antibody, which acts as a TN-R antagonist with hig